Gene · 7012
Papers4,156
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 4,156
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TElomeric repeat-containing RNA (TERRA): Physiological functions and relevance in cancer. | Front Oncol | 2022 | 35982970 | PubTator, text mining | PubMed |
| Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers. | Clin Transl Med | 2022 | 35979662 | PubTator, text mining | PubMed |
| Mobile Tigecycline Resistance: An Emerging Health Catastrophe Requiring Urgent One Health Global Intervention. | Front Microbiol | 2022 | 35979498 | PubTator, text mining | PubMed |
| Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center. | World J Gastroenterol | 2022 | 35978866 | PubTator, text mining | PubMed |
| Negative autoregulation mitigates collateral RNase activity of repeat-targeting CRISPR-Cas13d in mammalian cells. | Cell Rep | 2022 | 35977479 | PubTator, text mining | PubMed |
| Hormonal regulation of telomerase activity and hTERT expression in steroid-regulated tissues and cancer. | Cancer Cell Int | 2022 | 35974340 | PubTator, text mining | PubMed |
| Serotonin system is partially involved in immunomodulation of Nile tilapia (Oreochromis niloticus) immune cells. | Front Immunol | 2022 | 35967362 | PubTator, text mining | PubMed |
| CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with longer time to recurrence. | BMC Cancer | 2022 | 35962322 | PubTator, text mining | PubMed |
| Deep sequencing of short capped RNAs reveals novel families of noncoding RNAs. | Genome Res | 2022 | 35961773 | PubTator, text mining | PubMed |
| A Liquid Biopsy in Bladder Cancer-The Current Landscape in Urinary Biomarkers. | Int J Mol Sci | 2022 | 35955727 | PubTator, text mining | PubMed |
| SOX2 expression in the pathogenesis of premalignant lesions of the uterine cervix: its histo-topographical distribution distinguishes between low- and high-grade CIN. | Histochem Cell Biol | 2022 | 35945296 | PubTator, text mining | PubMed |
| Correlating SFTPC gene variants to interstitial lung disease in Egyptian children. | J Genet Eng Biotechnol | 2022 | 35939165 | PubTator, text mining | PubMed |
| Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis. | Front Pharmacol | 2022 | 35935869 | PubTator, text mining | PubMed |
| Germline thymidylate synthase deficiency impacts nucleotide metabolism and causes dyskeratosis congenita. | Am J Hum Genet | 2022 | 35931051 | PubTator, text mining | PubMed |
| Association of Newborn Telomere Length With Blood Pressure in Childhood. | JAMA Netw Open | 2022 | 35930283 | PubTator, text mining | PubMed |
| A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study. | Front Oncol | 2022 | 35928870 | PubTator, text mining | PubMed |
| Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia. | Leukemia | 2022 | 35927326 | PubTator, text mining | PubMed |
| Tieing together loose ends: telomere instability in cancer and aging. | Mol Oncol | 2022 | 35920280 | PubTator, text mining | PubMed |
| Telomere Attrition With Concomitant hTERT Overexpression Involved in the Progression of Gastric Cancer May Have Prognostic and Clinical Implications in High-Risk Population Group From North India. | Front Oncol | 2022 | 35912187 | PubTator, text mining | PubMed |
| Intersection of Inflammation and Senescence in the Aging Lung Stem Cell Niche. | Front Cell Dev Biol | 2022 | 35912114 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7012/papers?page=32